论文部分内容阅读
目的观察阿司匹林间歇疗法与常规疗法在脑卒中二级预防中临床价值的差异。方法收集250例脑卒中恢复期患者,按随机单盲开放对照原则分为间歇疗法组(间歇组)(每8周内停药1周)和常规疗法组(单规组)各125例,均给予阿司匹林100mg Qd治疗2年。结果(1)2组脑卒中再发率无明显差异;(2)2组患者的血小板聚集率和凝血功能无明显差异;(3)间歇组上消化道出血、腹痛、腹泻等不良反应发生率较常规组明显下降(P<0.01)。结论阿司匹林间歇疗法较常规疗法能有效减低了长期治疗导致的消化道不良反应,同时有效降低脑卒中的再发率,在脑卒中二级预防中具有重要的临床应用价值。
Objective To observe the clinical value of aspirin intermittent therapy and routine therapy in secondary prevention of stroke. Methods A total of 250 patients with convalescent stroke were enrolled. Patients were divided into intermittent group (intermittent group) (1 week for every 8 weeks) and 125 patients for conventional therapy group Give aspirin 100mg Qd for 2 years. Results (1) There was no significant difference in the recurrent rate of stroke among the two groups. (2) There was no significant difference in platelet aggregation rate and coagulation function between the two groups. (3) The incidence of upper gastrointestinal bleeding, abdominal pain and diarrhea Compared with the conventional group decreased significantly (P <0.01). Conclusion Aspirin intermittent therapy can effectively reduce the long-term treatment of gastrointestinal adverse reactions, reduce the incidence of recurrent stroke and have important clinical value in the secondary prevention of stroke.